The Republican vice presidential candidate said he ‘was in bed for two days.’
Vice presidential candidate Sen. JD Vance (R-Ohio) said in a recent podcast with Joe Rogan that he experienced serious side effects from a COVID-19 vaccine.
Vance in the interview confirmed to Rogan that he “took the vax” but has not “been boosted or anything.”
“The moment where I really started to get red-pilled on the whole vax thing was, the sickest that I’ve been in the last 15 years, by far, was when I took the vaccine,” Vance said.
Describing what happened, Vance said that he “was in bed for two days. My heart was racing … The fact that we’re not even allowed to talk about that … I was as sick as I’ve ever been for two days and the worst COVID experience I had was like a sinus infection—I’m not really willing to trade that.”
Rogan, who has often questioned the COVID-19 vaccines on his popular show, shared Vance’s sentiments.
“You’re not allowed to question it. You’re not allowed to discuss it,” Rogan said.
Rogan later said that there have been people “who have been vaccine injured, particularly people on the left” who are “very reluctant to discuss it” and scared of being identified as anti-vaccine.
Vance then said that an unnamed senator has also suffered side effects from the shot.
“I have a Senate colleague who doesn’t want to talk about it but worries that it’s permanently affected his sense of balance, dizziness, and vertigo, and it happens,” Vance said in response. “I’ve talked to a number of people who think that they got vaccine injured. Some of them are public about it, and some of them are not.”
Vance did not disclose which brand of vaccine he received or when he received it. The Epoch Times could not independently confirm the identity and experience of the senator Vance said was suffering from a vaccine-related side-effect.
The U.S. Centers for Disease Control and Prevention (CDC) has continued to recommend that Americans get the vaccine.
“Data continues to confirm the importance of vaccination to protect those most at risk for severe outcomes of COVID-19,” the agency said in a recent news release, issued on Oct. 23.
